The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artemisinin Antimalarial Drugs Market Research Report 2025
Synopsis
The global Artemisinin Antimalarial Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artemisinin Antimalarial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin Antimalarial Drugs.
Report Scope
The Artemisinin Antimalarial Drugs market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinin Antimalarial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin Antimalarial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sanofi
Ajanta
Cipla
Ipca
Guilin Medicine
GlaxoSmithKline
Mylan Labs
Roche
Segment by Type
Artesunate
Dihydroartemisinin
Artemether
Segment by Application
Prevention
Treatment
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinin Antimalarial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artemisinin Antimalarial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Artemisinin Antimalarial Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artemisinin Antimalarial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin Antimalarial Drugs.
Report Scope
The Artemisinin Antimalarial Drugs market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinin Antimalarial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin Antimalarial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sanofi
Ajanta
Cipla
Ipca
Guilin Medicine
GlaxoSmithKline
Mylan Labs
Roche
Segment by Type
Artesunate
Dihydroartemisinin
Artemether
Segment by Application
Prevention
Treatment
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinin Antimalarial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artemisinin Antimalarial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artemisinin Antimalarial Drugs Market Overview
1.1 Product Overview and Scope of Artemisinin Antimalarial Drugs
1.2 Artemisinin Antimalarial Drugs Segment by Type
1.2.1 Global Artemisinin Antimalarial Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Artesunate
1.2.3 Dihydroartemisinin
1.2.4 Artemether
1.3 Artemisinin Antimalarial Drugs Segment by Application
1.3.1 Global Artemisinin Antimalarial Drugs Market Value by Application: (2024-2030)
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Other
1.4 Global Artemisinin Antimalarial Drugs Market Size Estimates and Forecasts
1.4.1 Global Artemisinin Antimalarial Drugs Revenue 2019-2030
1.4.2 Global Artemisinin Antimalarial Drugs Sales 2019-2030
1.4.3 Global Artemisinin Antimalarial Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artemisinin Antimalarial Drugs Market Competition by Manufacturers
2.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artemisinin Antimalarial Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Artemisinin Antimalarial Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artemisinin Antimalarial Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artemisinin Antimalarial Drugs, Product Type & Application
2.7 Artemisinin Antimalarial Drugs Market Competitive Situation and Trends
2.7.1 Artemisinin Antimalarial Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artemisinin Antimalarial Drugs Players Market Share by Revenue
2.7.3 Global Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artemisinin Antimalarial Drugs Retrospective Market Scenario by Region
3.1 Global Artemisinin Antimalarial Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artemisinin Antimalarial Drugs Global Artemisinin Antimalarial Drugs Sales by Region: 2019-2030
3.2.1 Global Artemisinin Antimalarial Drugs Sales by Region: 2019-2024
3.2.2 Global Artemisinin Antimalarial Drugs Sales by Region: 2025-2030
3.3 Global Artemisinin Antimalarial Drugs Global Artemisinin Antimalarial Drugs Revenue by Region: 2019-2030
3.3.1 Global Artemisinin Antimalarial Drugs Revenue by Region: 2019-2024
3.3.2 Global Artemisinin Antimalarial Drugs Revenue by Region: 2025-2030
3.4 North America Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.4.1 North America Artemisinin Antimalarial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artemisinin Antimalarial Drugs Sales by Country (2019-2030)
3.4.3 North America Artemisinin Antimalarial Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.5.1 Europe Artemisinin Antimalarial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artemisinin Antimalarial Drugs Sales by Country (2019-2030)
3.5.3 Europe Artemisinin Antimalarial Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Artemisinin Antimalarial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artemisinin Antimalarial Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Artemisinin Antimalarial Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.7.1 Latin America Artemisinin Antimalarial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artemisinin Antimalarial Drugs Sales by Country (2019-2030)
3.7.3 Latin America Artemisinin Antimalarial Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artemisinin Antimalarial Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Artemisinin Antimalarial Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artemisinin Antimalarial Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artemisinin Antimalarial Drugs Sales by Type (2019-2030)
4.1.1 Global Artemisinin Antimalarial Drugs Sales by Type (2019-2024)
4.1.2 Global Artemisinin Antimalarial Drugs Sales by Type (2025-2030)
4.1.3 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2019-2030)
4.2 Global Artemisinin Antimalarial Drugs Revenue by Type (2019-2030)
4.2.1 Global Artemisinin Antimalarial Drugs Revenue by Type (2019-2024)
4.2.2 Global Artemisinin Antimalarial Drugs Revenue by Type (2025-2030)
4.2.3 Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Artemisinin Antimalarial Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artemisinin Antimalarial Drugs Sales by Application (2019-2030)
5.1.1 Global Artemisinin Antimalarial Drugs Sales by Application (2019-2024)
5.1.2 Global Artemisinin Antimalarial Drugs Sales by Application (2025-2030)
5.1.3 Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2019-2030)
5.2 Global Artemisinin Antimalarial Drugs Revenue by Application (2019-2030)
5.2.1 Global Artemisinin Antimalarial Drugs Revenue by Application (2019-2024)
5.2.2 Global Artemisinin Antimalarial Drugs Revenue by Application (2025-2030)
5.2.3 Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Artemisinin Antimalarial Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Artemisinin Antimalarial Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Artemisinin Antimalarial Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Ajanta
6.3.1 Ajanta Corporation Information
6.3.2 Ajanta Description and Business Overview
6.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ajanta Artemisinin Antimalarial Drugs Product Portfolio
6.3.5 Ajanta Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Artemisinin Antimalarial Drugs Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Ipca
6.5.1 Ipca Corporation Information
6.5.2 Ipca Description and Business Overview
6.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ipca Artemisinin Antimalarial Drugs Product Portfolio
6.5.5 Ipca Recent Developments/Updates
6.6 Guilin Medicine
6.6.1 Guilin Medicine Corporation Information
6.6.2 Guilin Medicine Description and Business Overview
6.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Guilin Medicine Artemisinin Antimalarial Drugs Product Portfolio
6.6.5 Guilin Medicine Recent Developments/Updates
6.7 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Portfolio
6.7.5 GlaxoSmithKline Recent Developments/Updates
6.8 Mylan Labs
6.8.1 Mylan Labs Corporation Information
6.8.2 Mylan Labs Description and Business Overview
6.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Labs Artemisinin Antimalarial Drugs Product Portfolio
6.8.5 Mylan Labs Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Artemisinin Antimalarial Drugs Product Portfolio
6.9.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artemisinin Antimalarial Drugs Industry Chain Analysis
7.2 Artemisinin Antimalarial Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artemisinin Antimalarial Drugs Production Mode & Process
7.4 Artemisinin Antimalarial Drugs Sales and Marketing
7.4.1 Artemisinin Antimalarial Drugs Sales Channels
7.4.2 Artemisinin Antimalarial Drugs Distributors
7.5 Artemisinin Antimalarial Drugs Customers
8 Artemisinin Antimalarial Drugs Market Dynamics
8.1 Artemisinin Antimalarial Drugs Industry Trends
8.2 Artemisinin Antimalarial Drugs Market Drivers
8.3 Artemisinin Antimalarial Drugs Market Challenges
8.4 Artemisinin Antimalarial Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Artemisinin Antimalarial Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Artemisinin Antimalarial Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Artemisinin Antimalarial Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Artemisinin Antimalarial Drugs Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Artemisinin Antimalarial Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Artemisinin Antimalarial Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Artemisinin Antimalarial Drugs Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Artemisinin Antimalarial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Artemisinin Antimalarial Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Artemisinin Antimalarial Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Artemisinin Antimalarial Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Artemisinin Antimalarial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinin Antimalarial Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Artemisinin Antimalarial Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Artemisinin Antimalarial Drugs Sales by Region (2019-2024) & (KG)
Table 18. Global Artemisinin Antimalarial Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Artemisinin Antimalarial Drugs Sales by Region (2025-2030) & (KG)
Table 20. Global Artemisinin Antimalarial Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Artemisinin Antimalarial Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Artemisinin Antimalarial Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Artemisinin Antimalarial Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Artemisinin Antimalarial Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Artemisinin Antimalarial Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Artemisinin Antimalarial Drugs Sales by Country (2019-2024) & (KG)
Table 27. North America Artemisinin Antimalarial Drugs Sales by Country (2025-2030) & (KG)
Table 28. North America Artemisinin Antimalarial Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Artemisinin Antimalarial Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Artemisinin Antimalarial Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Artemisinin Antimalarial Drugs Sales by Country (2019-2024) & (KG)
Table 32. Europe Artemisinin Antimalarial Drugs Sales by Country (2025-2030) & (KG)
Table 33. Europe Artemisinin Antimalarial Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Artemisinin Antimalarial Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Artemisinin Antimalarial Drugs Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Artemisinin Antimalarial Drugs Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Artemisinin Antimalarial Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Artemisinin Antimalarial Drugs Sales by Country (2019-2024) & (KG)
Table 42. Latin America Artemisinin Antimalarial Drugs Sales by Country (2025-2030) & (KG)
Table 43. Latin America Artemisinin Antimalarial Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Artemisinin Antimalarial Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Artemisinin Antimalarial Drugs Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Artemisinin Antimalarial Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Artemisinin Antimalarial Drugs Sales (KG) by Type (2019-2024)
Table 51. Global Artemisinin Antimalarial Drugs Sales (KG) by Type (2025-2030)
Table 52. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Artemisinin Antimalarial Drugs Price (US$/G) by Type (2019-2024)
Table 59. Global Artemisinin Antimalarial Drugs Price (US$/G) by Type (2025-2030)
Table 60. Global Artemisinin Antimalarial Drugs Sales (KG) by Application (2019-2024)
Table 61. Global Artemisinin Antimalarial Drugs Sales (KG) by Application (2025-2030)
Table 62. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Artemisinin Antimalarial Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Artemisinin Antimalarial Drugs Price (US$/G) by Application (2019-2024)
Table 69. Global Artemisinin Antimalarial Drugs Price (US$/G) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Novartis Artemisinin Antimalarial Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Sanofi Artemisinin Antimalarial Drugs Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Ajanta Corporation Information
Table 81. Ajanta Description and Business Overview
Table 82. Ajanta Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Ajanta Artemisinin Antimalarial Drugs Product
Table 84. Ajanta Recent Developments/Updates
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Cipla Artemisinin Antimalarial Drugs Product
Table 89. Cipla Recent Developments/Updates
Table 90. Ipca Corporation Information
Table 91. Ipca Description and Business Overview
Table 92. Ipca Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Ipca Artemisinin Antimalarial Drugs Product
Table 94. Ipca Recent Developments/Updates
Table 95. Guilin Medicine Corporation Information
Table 96. Guilin Medicine Description and Business Overview
Table 97. Guilin Medicine Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Guilin Medicine Artemisinin Antimalarial Drugs Product
Table 99. Guilin Medicine Recent Developments/Updates
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. GlaxoSmithKline Artemisinin Antimalarial Drugs Product
Table 104. GlaxoSmithKline Recent Developments/Updates
Table 105. Mylan Labs Corporation Information
Table 106. Mylan Labs Description and Business Overview
Table 107. Mylan Labs Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Mylan Labs Artemisinin Antimalarial Drugs Product
Table 109. Mylan Labs Recent Developments/Updates
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Artemisinin Antimalarial Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Roche Artemisinin Antimalarial Drugs Product
Table 114. Roche Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Artemisinin Antimalarial Drugs Distributors List
Table 118. Artemisinin Antimalarial Drugs Customers List
Table 119. Artemisinin Antimalarial Drugs Market Trends
Table 120. Artemisinin Antimalarial Drugs Market Drivers
Table 121. Artemisinin Antimalarial Drugs Market Challenges
Table 122. Artemisinin Antimalarial Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artemisinin Antimalarial Drugs
Figure 2. Global Artemisinin Antimalarial Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Artemisinin Antimalarial Drugs Market Share by Type in 2023 & 2030
Figure 4. Artesunate Product Picture
Figure 5. Dihydroartemisinin Product Picture
Figure 6. Artemether Product Picture
Figure 7. Global Artemisinin Antimalarial Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Artemisinin Antimalarial Drugs Market Share by Application in 2023 & 2030
Figure 9. Prevention
Figure 10. Treatment
Figure 11. Other
Figure 12. Global Artemisinin Antimalarial Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Artemisinin Antimalarial Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Artemisinin Antimalarial Drugs Sales (2019-2030) & (KG)
Figure 15. Global Artemisinin Antimalarial Drugs Average Price (US$/G) & (2019-2030)
Figure 16. Artemisinin Antimalarial Drugs Report Years Considered
Figure 17. Artemisinin Antimalarial Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Artemisinin Antimalarial Drugs Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Artemisinin Antimalarial Drugs Players: Market Share by Revenue in 2023
Figure 20. Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Artemisinin Antimalarial Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Artemisinin Antimalarial Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Artemisinin Antimalarial Drugs Revenue Market Share by Country (2019-2030)
Figure 24. United States Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Artemisinin Antimalarial Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Artemisinin Antimalarial Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Artemisinin Antimalarial Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Artemisinin Antimalarial Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Artemisinin Antimalarial Drugs Sales Market Share by Country (2019-2030)
Figure 45. Latin America Artemisinin Antimalarial Drugs Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Artemisinin Antimalarial Drugs Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Artemisinin Antimalarial Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Artemisinin Antimalarial Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Artemisinin Antimalarial Drugs by Type (2019-2030)
Figure 55. Global Revenue Market Share of Artemisinin Antimalarial Drugs by Type (2019-2030)
Figure 56. Global Artemisinin Antimalarial Drugs Price (US$/G) by Type (2019-2030)
Figure 57. Global Sales Market Share of Artemisinin Antimalarial Drugs by Application (2019-2030)
Figure 58. Global Revenue Market Share of Artemisinin Antimalarial Drugs by Application (2019-2030)
Figure 59. Global Artemisinin Antimalarial Drugs Price (US$/G) by Application (2019-2030)
Figure 60. Artemisinin Antimalarial Drugs Value Chain
Figure 61. Artemisinin Antimalarial Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
